A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
Clinical trial NCT03997786 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03997786
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2025-04-07
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.